{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:39:02Z","timestamp":1790069942906,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jpba.2013.01.027","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T06:01:38Z","timestamp":1360303298000},"page":"52-56","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Development and validation of a stability indicating method for seven novel derivatives of lamivudine with anti-HIV and anti-HBV activity in simulated gastric and intestinal fluids"],"prefix":"10.1016","volume":"78-79","author":[{"given":"Mar\u00eda S.","family":"Gualdesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Esteve-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita C.","family":"Bri\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica A.","family":"Raviolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2013.01.027_bib0005","series-title":"AIDS Epidemic Update","author":"UNAIDS","year":"2007"},{"key":"10.1016\/j.jpba.2013.01.027_bib0010","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2174\/1381612053764869","article-title":"Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome","volume":"11","author":"Barbaro","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpba.2013.01.027_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/373123a0","article-title":"Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection","volume":"373","author":"Ho","year":"1995","journal-title":"Nature (London)"},{"key":"10.1016\/j.jpba.2013.01.027_bib0020","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJM199610103351501","article-title":"A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team","volume":"335","author":"Hammer","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2013.01.027_bib0025","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/00002030-200311070-00009","article-title":"Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine","volume":"17","author":"Gulick","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jpba.2013.01.027_bib0030","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1086\/507532","article-title":"Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls","volume":"43","author":"Levy","year":"2006","journal-title":"HIV\/AIDS Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2013.01.027_bib0035","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1016\/j.bmc.2009.07.032","article-title":"Synthesis anti-HIV activity of novel 2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine prodrugs, Bioorg","volume":"17","author":"Ravetti","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.jpba.2013.01.027_bib0040","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ijantimicag.2010.08.012","article-title":"Antiviral activity of 5\u2032-O-carbonate-2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine prodrugs against hepatitis B virus in HepG2 2.2.15 cells","volume":"36","author":"Gagey","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jpba.2013.01.027_bib0045","series-title":"Guidance for Industry, Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System","year":"2000"},{"key":"10.1016\/j.jpba.2013.01.027_bib0050","series-title":"Guidance for Industry, Bioanalytical, Method Validation","year":"2001"},{"key":"10.1016\/j.jpba.2013.01.027_bib0055","series-title":"The Fitness for Purpose of Analytical Methods: A Laboratory Guide to Method Validation and Related Topics","author":"Eurachem Working Group","year":"1998"},{"key":"10.1016\/j.jpba.2013.01.027_bib0060","series-title":"Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","author":"ICH Q2(R1)","year":"2005"},{"key":"10.1016\/j.jpba.2013.01.027_bib0065","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jpba.2004.06.018","article-title":"Validation in pharmaceutical analysis. Part II: central importance of precision to establish acceptance criteria and for verifying and improving the quality of analytical data","volume":"37","author":"Ermer","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.01.027_bib0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.trac.2004.11.003","article-title":"Micellar liquid chromatography for the determination of drug materials in pharmaceutical preparations and biological samples","volume":"24","author":"Esteve-Romero","year":"2005","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2013.01.027_bib0075","unstructured":"M.S. Gualdesi, S. Ravetti, M.A. Raviolo, M.C. Bri\u00f1\u00f3n, Preformulation studies of novel 5\u2032-O-carbonates of lamivudine with biological activity: solubility and stability assays, J. Pharm. Pharmacol., unpublished results."},{"key":"10.1016\/j.jpba.2013.01.027_bib0080","unstructured":"Test Test solutions, United States Pharmacopoeia 32\/National Formulary 27, 2009."},{"key":"10.1016\/j.jpba.2013.01.027_bib0085","series-title":"Michrom Software","author":"Torres-Lapasi\u00f3","year":"2000"},{"key":"10.1016\/j.jpba.2013.01.027_bib0090","unstructured":"A.C. Guyton, J.E. Hall, Secretory functions of the alimentary tract, Textbook of Medical Physiology, Philadelphia, 2006, pp. 791\u2013807."},{"key":"10.1016\/j.jpba.2013.01.027_bib0095","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1080\/10826070801924857","article-title":"Lipophilicity of novel 5\u2032-carbonates of lamivudine with antirretroviral activity. Correlation between different methods","volume":"31","author":"Ravetti","year":"2008","journal-title":"J. Liq. Chromatogr."},{"key":"10.1016\/j.jpba.2013.01.027_bib0100","series-title":"Chemical Stability of Drug Substances, Stability of Drugs and Dosage Forms","author":"Yoshioka","year":"2000"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T18:31:29Z","timestamp":1539887489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708513000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":20,"alternative-id":["S0731708513000368"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2013.01.027","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}